Drug
VX-150 clinical trials
Also written VX-150.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses VX-150 is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Microneurography Study of NaV1.8 Inhibition in Healthy AdultsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06420765Written as VX-150
- A Microneurography (MNG) Study of VX-150 in Healthy ParticipantsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT05418712Written as VX-150
- A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT03764072Written as VX-150
- A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber NeuropathyCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT03304522Written as VX-150
- A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT03206749Written as VX-150
- A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the KneeCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT02660424Written as VX-150